Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron Variant
No direct data yet available testing the new variant's resistance to immunity from monoclonal antibodies and vaccines
Decline in Infectious Conjunctivitis During COVID-19 Pandemic
Decrease in emergency department encounters for nonallergic conjunctivitis after adoption of public health measures to curb COVID-19
SARS-CoV-2 Infection Up >90 Days Since Second BNT162b2 Dose
Individuals who tested positive for SARS-CoV-2 had significantly longer time elapsed since vaccine injection
FDA Approves Livtencity for Posttransplant Cytomegalovirus
Livtencity is indicated for posttransplant CMV that does not respond to available antiviral treatments
Merck’s COVID-19 Pill Appears Effective, but May Pose Pregnancy Risks: FDA
Given safety concerns, FDA scientists said Merck has agreed the drug will not be used in children.
Biden Pushes Vaccines, Masks as Best Defense Against Omicron Variant
News reports out of South Africa noted that COVID-19 cases from omicron have resulted in mostly mild symptoms
Vaccine Makers Already Testing Their Shots Against Omicron Variant
So far, existing vaccines have proven effective against prior coronavirus variants, including the delta variant
Thanksgiving Weekend Brought New COVID-19 Concerns: the Omicron Variant
On Saturday, the CDC issued a statement stressing that 'no cases of this variant have been identified in the U.S. to date'
Cervical Cancer Deaths Down Following HPV Vaccine Introduction
Reductions in cervical cancer incidence, mortality in the U.S. greater for those aged 15 to 24 years than those aged 25 to 29, 30 to 39 years
Caregivers of Childhood Cancer Survivors Concerned About COVID-19 Vaccines
Concerns, expressed early in the rollout, included lack of safety and efficacy data, particularly in children with cancer
